Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy
Crossref DOI link: https://doi.org/10.1039/D3NH00061C
Published Online: 2023
Update policy: https://doi.org/10.1039/rsc_crossmark_policy
Jiang, Gexuan
Xiang, Zhichu
Fang, Qiaojun https://orcid.org/0000-0002-2856-3281
Funding for this research was provided by:
National Key Research and Development Program of China (2022YFA1203200)
Chinese Academy of Sciences (XDB36000000)
Version of Record valid from 2023-11-30
